Dr. Simona F. Oprea, MD

Dr. Oprea practices at HCA HealthONE Swedish in Englewood, Colorado, part of HCA Healthcare.

Dr. Oprea's NPI, 1194711416, was assigned on September 22, 2005. Dr. Oprea graduated from Iuliu Hatieganu University of Medicine and Pharmacy in 1997. Dr. Oprea's Illinois license number on file is 036-113000.

Dr. Oprea's primary practice is HCA HealthONE Swedish, at 501 E Hampden Ave, Englewood, CO 80113 in Arapahoe County. The practice phone is (303) 788-5000.

Dr. Oprea's primary practice is HCA HealthONE Swedish in Englewood, Colorado, part of HCA Healthcare. Dr. Oprea is also affiliated with AdventHealth Porter. The medical group on file is Colorado Infectious Disease Associates. Dmand AI also links Dr. Oprea to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oprea practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Oprea's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Oprea is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Oprea's licenses on file in 3 states: Illinois, Colorado and Michigan.

Dmand AI lists hiv/aids, immune deficiency disease and joint or bone infection among the conditions Dr. Oprea treats.

CMS data shows 343 Medicare services from Dr. Oprea across 4 procedure codes in 2024, for 154 Medicare patients. Medicare paid $29,398 for them.

CMS counts 154 Medicare patients who saw Dr. Oprea in 2024. The largest group is 75 to 84, with 53 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Oprea's median patient age at 70, with 43% women.

In 2024, Dr. Oprea wrote 118 Medicare Part D claims for 19 patients. 85% of them were for generic drugs. CMS names the drug for 65 of them, across 4 drugs with 11 or more claims each, at $48,309 in total drug cost. In 2023, CMS named 92 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Oprea for performance year 2024, reported as part of a group. Dr. Oprea accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Oprea as offering telehealth.

Dmand AI links 3 papers to Dr. Oprea in 2004. 2004 was the busiest year, with 2. The most frequent topics are Enterococcus faecalis and Gram-Positive Bacterial Infections. Dr. Oprea has published most often in J Antimicrob Chemother.

CMS Open Payments shows 106 general payments to Dr. Oprea from 11 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $1,256.

Dmand AI lists 1 award for Dr. Oprea, most recently CMS Stage 1 EHR in 2013.

Dr. Oprea graduated from Iuliu Hatieganu University of Medicine and Pharmacy in 1997.

Dr. Oprea is in network with 16 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.